Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Lysosomal Protein Transmembrane 4 beta (LAPTM4B) (Middle Region) Peptide

LAPTM4B Hôte: Synthetic BP, WB, IHC
N° du produit ABIN8104700
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Lysosomal Protein Transmembrane 4 beta (LAPTM4B) (Middle Region) Peptide (ABIN8104700)

Antigène

LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein Region

    Middle Region

    Fonction

    LAPTM4B Peptide - middle region
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-LAPTM4B antibody ( ARP47442_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))

    Sujet

    Background Information: LAPTM4B is a multi-pass membrane protein. It belongs to the LAPTM4/LAPTM5 transporter family. LAPTM4b has active role in disease progression of malignant cells and is involved in cell proliferation and multidrug resistance. The genetic polymorphism of LAPTM4B is a potential risk factor for the development of colon cancer and gastric cancer. The research results also indicated that LAPTM4B may be a clinically useful prognostic indicator for ovarian carcinoma and may play a role in human hepatocellular carcinoma.

    Alternative Symbols: LAPTM4beta, LC27

    Poids moléculaire

    35kDa

    ID gène

    55353

    NCBI Accession

    NP_060877

    UniProt

    Q86VI4
Vous êtes ici:
Chat with us!